Detalles de la búsqueda
1.
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
N Engl J Med
; 388(23): 2159-2170, 2023 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36972022
2.
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 468-482, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080223
3.
Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study.
Gynecol Oncol
; 171: 67-75, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36827840
4.
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
Gynecol Oncol
; 177: 38-45, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634258
5.
A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer.
Future Oncol
; 19(25): 1709-1714, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37381977
6.
Frailty as a predictor of delayed initiation of adjuvant chemotherapy in patients with ovarian cancer.
Int J Gynecol Cancer
; 33(1): 57-65, 2023 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36423959
7.
An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer.
Oncologist
; 27(12): 1058-1066, 2022 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36124638
8.
Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis.
Gynecol Oncol
; 166(3): 425-431, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803835
9.
Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab.
Int J Gynecol Cancer
; 2022 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973737
10.
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial.
Lancet Oncol
; 22(5): 632-642, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33862001
11.
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 379(26): 2495-2505, 2018 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30345884
12.
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial.
Gynecol Oncol
; 163(1): 41-49, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34353615
13.
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function.
Gynecol Oncol
; 160(1): 244-251, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33109392
14.
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women.
Gynecol Oncol
; 160(3): 660-668, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33423806
15.
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.
Gynecol Oncol
; 161(2): 512-515, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33610319
16.
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.
Gynecol Oncol
; 161(1): 113-121, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33541735
17.
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer.
Future Oncol
; 17(29): 3781-3785, 2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34427115
18.
A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer.
Gynecol Oncol
; 156(1): 13-22, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31708167
19.
GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients.
Gynecol Oncol
; 156(2): 467-474, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31837831
20.
The Association Between Mindfulness and Postoperative Pain: A Prospective Cohort Study of Gynecologic Oncology Patients Undergoing Minimally Invasive Hysterectomy.
J Minim Invasive Gynecol
; 27(5): 1119-1126.e2, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31449907